INTRANASAL AGENT "OKSOFIL" FOR TREATMENT AND PROPHYLAXIS OF RHINITIS OF DIFFERENT ETIOLOGY

FIELD: medicine, otorhinolaryngology, pharmacy. SUBSTANCE: invention relates to compositions used for external (intranasal) application. Invention relates to intranasal agent that comprises drops containing acutifoliate oxytropis (Oxytropis oxyphylla (Pall. ) DC) dry extract. Hydrophilic-base drops...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KABISHEV K.EH, SOLOV'EVA U.G, POTEKHINA T.S, BAKHTINA S.M, SAKANJAN E.I, LESIOVSKAJA E.E
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, otorhinolaryngology, pharmacy. SUBSTANCE: invention relates to compositions used for external (intranasal) application. Invention relates to intranasal agent that comprises drops containing acutifoliate oxytropis (Oxytropis oxyphylla (Pall. ) DC) dry extract. Hydrophilic-base drops are preferable in acute form of rhinitis and present extract suspension in hydroxymethylcellulose aqueous solution and comprise sorbic acid. Emulsion-base drops are preferable for recovery of mucosa tissue in chronic rhinitis and present emulsion-base suspension comprising peach oil, emulsifier T-2, preparation OS-20, propylene glycol, water and sorbic acid. Drops based on hydrophilic and emulsion bases are recommended in complex therapy route. Invention provides preparing nontoxic preparation without adverse effects. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 4 cl, 7 tbl, 3 dwg